These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28195591)

  • 21. Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.
    Karmakar P; Lee K; Sarkar S; Wall KA; Sucheck SJ
    Bioconjug Chem; 2016 Jan; 27(1):110-20. PubMed ID: 26595674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
    Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
    Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: A multi-component reaction for the synthesis of pyrido [1,2-
    Shinde SS; Laha S; Tiwari DK; Sridhar B; Likhar PR
    Org Biomol Chem; 2020 Nov; 18(42):8746. PubMed ID: 33084714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice.
    Stergiou N; Glaffig M; Jonuleit H; Schmitt E; Kunz H
    ChemMedChem; 2017 Sep; 12(17):1424-1428. PubMed ID: 28675699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MUC1 as a potential target in anticancer therapies.
    Pillai K; Pourgholami MH; Chua TC; Morris DL
    Am J Clin Oncol; 2015 Feb; 38(1):108-18. PubMed ID: 23608828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition.
    Nepali K; Kumar S; Huang HL; Kuo FC; Lee CH; Kuo CC; Yeh TK; Li YH; Chang JY; Liou JP; Lee HY
    Org Biomol Chem; 2018 Jul; 16(25):4734. PubMed ID: 29904758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Synthesis and biological evaluation of pyrazolo-triazole hybrids as cytotoxic and apoptosis inducing agents.
    Srinivasa Reddy T; Kulhari H; Ganga Reddy V; Subba Rao AV; Bansal V; Kamal A; Shukla R
    Org Biomol Chem; 2019 Aug; 17(30):7247. PubMed ID: 31317166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: Intermolecular interactions boost aggregation induced emission in carbazole Schiff base derivatives.
    Gan X; Liu G; Chu M; Xi W; Ren Z; Zhang X; Tian Y; Zhou H
    Org Biomol Chem; 2017 Mar; 15(9):2119. PubMed ID: 28177024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic and immunological studies on trimeric MUC1 immunodominant motif antigen-based anti-cancer vaccine candidates.
    Li M; Yu F; Yao C; Wang PG; Liu Y; Zhao W
    Org Biomol Chem; 2018 Feb; 16(6):993-999. PubMed ID: 29345713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: Substrate specificity of FUT8 and chemoenzymatic synthesis of core-fucosylated asymmetric N-glycans.
    Calderon AD; Liu Y; Li X; Wang X; Chen X; Li L; Wang PG
    Org Biomol Chem; 2016 May; 14(19):4542. PubMed ID: 27139574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer.
    Scheid E; Major P; Bergeron A; Finn OJ; Salter RD; Eady R; Yassine-Diab B; Favre D; Peretz Y; Landry C; Hotte S; Mukherjee SD; Dekaban GA; Fink C; Foster PJ; Gaudet J; Gariepy J; Sekaly RP; Lacombe L; Fradet Y; Foley R
    Cancer Immunol Res; 2016 Oct; 4(10):881-892. PubMed ID: 27604597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
    Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
    ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: Ionic-liquid supported rapid synthesis of an N-glycan core pentasaccharide on a 10 g scale.
    Li W; Gao Y; Li Q; Li ZJ
    Org Biomol Chem; 2019 Feb; 17(6):1572. PubMed ID: 30681122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: Nickel-catalyzed cyanation of phenol derivatives activated by 2,4,6-trichloro-1,3,5-triazine.
    Wang L; Wang Y; Shen J; Chen Q; He MY
    Org Biomol Chem; 2020 May; 18(19):3767. PubMed ID: 32377659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.
    Thompson P; Lakshminarayanan V; Supekar NT; Bradley JM; Cohen PA; Wolfert MA; Gendler SJ; Boons GJ
    Chem Commun (Camb); 2015 Jun; 51(50):10214-7. PubMed ID: 26022217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.
    Ragupathi G; Coltart DM; Williams LJ; Koide F; Kagan E; Allen J; Harris C; Glunz PW; Livingston PO; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13699-704. PubMed ID: 12359877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: Transfection efficiencies of α-tocopherylated cationic gemini lipids with hydroxyethyl bearing headgroups under high serum conditions.
    Maiti B; Kamra M; Karande AA; Bhattacharya S
    Org Biomol Chem; 2019 Feb; 17(8):2288. PubMed ID: 30720834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: Lacto-N-tetraose synthesis by wild-type and glycosynthase variants of the β-N-hexosaminidase from Bifidobacterium bifidum.
    Schmölzer K; Weingarten M; Baldenius K; Nidetzky B
    Org Biomol Chem; 2019 Jun; 17(23):5849. PubMed ID: 31161187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains.
    Matsushita T; Sadamoto R; Ohyabu N; Nakata H; Fumoto M; Fujitani N; Takegawa Y; Sakamoto T; Kurogochi M; Hinou H; Shimizu H; Ito T; Naruchi K; Togame H; Takemoto H; Kondo H; Nishimura S
    Biochemistry; 2009 Nov; 48(46):11117-33. PubMed ID: 19852465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.